Aprotinin shortage status
1 active shortage notice across 1 country.
Last updated 2 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Aprotinin
- Brand names
- Trasylol
- ATC code
- B02AB01
- Class
- Auto-created by Health Canada — Drug Shortages Database scraper
Where Aprotinin is in shortage
Why Aprotinin is in shortage
- causes not stated by the regulator
Recent shortage history
- Singapore: resolved 28 Oct 2025 (began 28 Oct 2025)
- Norway: resolved 31 Dec 2025 (began 23 Jul 2024)
Frequently asked questions
Is Aprotinin currently in shortage?
Yes. As of the latest regulator updates, Aprotinin has 1 active shortage notice across 1 country (Canada). Status is refreshed daily from official regulatory sources.
Why is Aprotinin in shortage?
Regulators attribute the current Aprotinin shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Aprotinin shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Related medicines
Tranexamic-Acid · 6-Aminocaproic Acid · Aminocaproic Acid
Get alerted when Aprotinin status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.